Company_Context
Basic Materials
Pharmaceutical Preparations
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
4 directional transactions in 30D
Code P purchases and code S sales are measured from 2026.07.17 — 2026.08.15.
+$2.9M
Open-market buys minus sales2026.08.12
Latest available filing4
Reporting entities in windowBOURLA ALBERT
$1.0MDAMICO JENNIFER B.
$83.3KAnalysis of eligible SEC Form 4 activity for PFE indicates a bullish 30-day signal. The selected window contains transactions from 4 distinct reporting insiders, with aggregate nominal activity of $3.04M.
Open-market purchases minus open-market sales produce a positive net flow of $2.88M. Open-market executions represent the majority of measured nominal activity in this window, making the directional flow more representative of voluntary trading activity.
BOURLA ALBERT recorded the largest aggregate purchase volume, while DAMICO JENNIFER B. recorded the largest aggregate sale volume. Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Basic Materials
Pharmaceutical Preparations
0
Clustered open-market purchase records in the recent filing sample.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 30D headline signal window.
The most recent insider transaction on record was filed on 2026.08.12. InsiderAlpha monitors EDGAR filings and updates this terminal as new Form 4 documents are published.
The selected 30-day window contains 4 distinct reporting insiders with eligible transactions for PFE. This count changes when a different signal window is selected.
Open-market buying volume ($2.96M) currently exceeds selling volume ($0.08M), suggesting net accumulation by insiders.
DAMICO JENNIFER B.
OPEN_MARKET_SALESVP & Controller · 2026.06.09
30D
-5.6%
90D
PENDING
180D
PENDING
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.